OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2025 (Form 8-K)

OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2025

BANNOCKBURN, IL., February 24, 2026 - Option Care Health, Inc. (the "Company" or "Option Care Health") (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter and full year ended December 31, 2025.

Fourth Quarter 2025 Financial Highlights

(year-over-year comparisons unless otherwise noted)

•Net revenue of $1,465.4 million, up 8.8%

•Net income of $58.5 million, down 2.7%

•GAAP diluted earnings per share of $0.37, up 5.7%

•Adjusted EBITDA of $126.0 million, up 3.7%

•Adjusted diluted earnings per share of $0.46, up 4.5%

•Repurchased $95 million of stock in the quarter

Full Year 2025 Financial Highlights

(year-over-year comparisons unless otherwise noted)

•Net revenue of $5,649.5 million, up 13.0%

•Net income of $207.6 million, down 2.0%

•GAAP diluted earnings per share of $1.27, up 3.3%

•Adjusted EBITDA of $471.3 million, up 6.2%

•Adjusted diluted earnings per share of $1.72, up 8.9%

•Cash provided by operating activities of $258.4 million

•Repurchased $307 million of stock in the year

John C. Rademacher, Chief Executive Officer, commented, "Our team continued to execute at a very high level to deliver extraordinary care and solid results in the fourth quarter and full year of 2025. During 2025, we served over 315,000 patients and they remain at the center of everything we do. We continued to make significant progress against our key priorities to build a sustainable growth enterprise while navigating a dynamic industry environment. As we look ahead in 2026, I am excited about the opportunities to further our mission and capitalize on the positive long-term growth trends across our industry and the strength of our position to serve more patients."

Full Year 2026 Financial Guidance

For the full year 2026, Option Care Health expects to deliver the following financial results:

•Net revenue of $5.8 billion to $6.0 billion

•Adjusted diluted earnings per share of $1.82 to $1.92

•Adjusted EBITDA of $480 million to $505 million

•Cash provided by operating activities of at least $340 million

Conference Call

Option Care Health will host a conference call to discuss its results on Tuesday, February 24, 2026, at 8:30 a.m. ET. The conference call can be accessed via a live audio webcast that will be available online at investors.optioncarehealth.com. A replay of the call will be available at the same web link for 90 days after the call.

About Option Care Health

Option Care Health is the nation's largest independent provider of home and alternate site infusion services. With over 8,000 team members, including more than 5,000 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and team members. To learn more, please visit our website at optioncarehealth.com.

Investor Contact

Nicole Maggio
Senior Vice President, Corporate Controller
[email protected]

Forward-Looking Statements - Safe Harbor